APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diabetic Retinopathy Screening Solution

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Diabetic Retinopathy Screening Solution Market Outlook and Growth Opportunities 2026

5 June 2026194 pages

Choose your research edition.

Industry ResearchDiabetic Retinopathy Screening Solution Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Diabetic Retinopathy Screening Solution Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Diabetic Retinopathy Screening Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diabetic Retinopathy Screening Solution Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Diabetic Retinopathy Screening Solution Market Analysis and Forecast 2026-2032181 pages · $4,950 USD

Market perspective

The global Diabetic Retinopathy Screening Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Diabetic Retinopathy Screening Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Diabetic Retinopathy Screening Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Diabetic Retinopathy Screening Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Diabetic Retinopathy Screening Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Diabetic Retinopathy Screening Solution market include RETINA-AI Health, IRIS, Retina Labs, CheckEye, RetinaLyze, NEC Software, InHealth Intelligence, RetinaRisk and Thirona Retina, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Diabetic Retinopathy Screening Solution market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Diabetic Retinopathy Screening Solution and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Diabetic Retinopathy Screening Solution revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Diabetic Retinopathy Screening Solution market.

Diabetic Retinopathy Screening Solution Segment by Company

RETINA-AI Health

IRIS

Retina Labs

CheckEye

RetinaLyze

NEC Software

InHealth Intelligence

RetinaRisk

Thirona Retina

Synapxe

Eyenuk

EyRIS (SELENA+)

Vistel

Diabetic Retinopathy Screening Solution Segment by Type

Traditional

Artificial Intelligence

Others

Diabetic Retinopathy Screening Solution Segment by Application

Medical Industry

Scientific Research

Others

Diabetic Retinopathy Screening Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Diabetic Retinopathy Screening Solution status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Diabetic Retinopathy Screening Solution key companies, revenue, market share, and recent developments.

3. To split the Diabetic Retinopathy Screening Solution breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Diabetic Retinopathy Screening Solution market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Diabetic Retinopathy Screening Solution significant trends, drivers, influence factors in global and regions.

6. To analyze Diabetic Retinopathy Screening Solution competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diabetic Retinopathy Screening Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diabetic Retinopathy Screening Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diabetic Retinopathy Screening Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Diabetic Retinopathy Screening Solution industry.

Chapter 3: Detailed analysis of Diabetic Retinopathy Screening Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Diabetic Retinopathy Screening Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Diabetic Retinopathy Screening Solution in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Diabetic Retinopathy Screening Solution Industry Trends Table 2. Diabetic Retinopathy Screening Solution Industry Drivers Table 3. Diabetic Retinopathy Screening Solution Industry Opportunities and Challenges Table 4. Diabetic Retinopathy Screening Solution Industry Restraints Table 5. Global Diabetic Retinopathy Screening Solution Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Diabetic Retinopathy Screening Solution Revenue Share by Company (2021-2026) Table 7. Global Diabetic Retinopathy Screening Solution Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Diabetic Retinopathy Screening Solution Key Company Manufacturing Base & Headquarters Table 9. Global Diabetic Retinopathy Screening Solution Company, Product Type & Application Table 10. Global Diabetic Retinopathy Screening Solution Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Diabetic Retinopathy Screening Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Traditional Table 15. Significant Companies of Artificial Intelligence Table 16. Significant Companies of Others Table 17. Global Diabetic Retinopathy Screening Solution Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Diabetic Retinopathy Screening Solution Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Diabetic Retinopathy Screening Solution Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Diabetic Retinopathy Screening Solution Sales Value Share by Type (2021-2026) Table 21. Global Diabetic Retinopathy Screening Solution Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Medical Industry Table 23. Significant Companies of Scientific Research Table 24. Significant Companies of Others Table 25. Global Diabetic Retinopathy Screening Solution Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Diabetic Retinopathy Screening Solution Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Diabetic Retinopathy Screening Solution Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Diabetic Retinopathy Screening Solution Sales Value Share by Application (2021-2026) Table 29. Global Diabetic Retinopathy Screening Solution Sales Value Share by Application (2027-2032) Table 30. Global Diabetic Retinopathy Screening Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Diabetic Retinopathy Screening Solution Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Diabetic Retinopathy Screening Solution Sales Value Share by Region (2021-2026) Table 33. Global Diabetic Retinopathy Screening Solution Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Diabetic Retinopathy Screening Solution Sales Value Share by Region (2027-2032) Table 35. Global Diabetic Retinopathy Screening Solution Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Diabetic Retinopathy Screening Solution Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Diabetic Retinopathy Screening Solution Sales Value Market Share by Country (2021-2026) Table 38. Global Diabetic Retinopathy Screening Solution Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Diabetic Retinopathy Screening Solution Sales Value Market Share by Country (2027-2032) Table 40. RETINA-AI Health Company Information Table 41. RETINA-AI Health Business Overview Table 42. RETINA-AI Health Diabetic Retinopathy Screening Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. RETINA-AI Health Diabetic Retinopathy Screening Solution Product Portfolio Table 44. RETINA-AI Health Recent Development Table 45. IRIS Company Information Table 46. IRIS Business Overview Table 47. IRIS Diabetic Retinopathy Screening Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. IRIS Diabetic Retinopathy Screening Solution Product Portfolio Table 49. IRIS Recent Development Table 50. Retina Labs Company Information Table 51. Retina Labs Business Overview Table 52. Retina Labs Diabetic Retinopathy Screening Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Retina Labs Diabetic Retinopathy Screening Solution Product Portfolio Table 54. Retina Labs Recent Development Table 55. CheckEye Company Information Table 56. CheckEye Business Overview Table 57. CheckEye Diabetic Retinopathy Screening Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. CheckEye Diabetic Retinopathy Screening Solution Product Portfolio Table 59. CheckEye Recent Development Table 60. RetinaLyze Company Information Table 61. RetinaLyze Business Overview Table 62. RetinaLyze Diabetic Retinopathy Screening Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. RetinaLyze Diabetic Retinopathy Screening Solution Product Portfolio Table 64. RetinaLyze Recent Development Table 65. NEC Software Company Information Table 66. NEC Software Business Overview Table 67. NEC Software Diabetic Retinopathy Screening Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. NEC Software Diabetic Retinopathy Screening Solution Product Portfolio Table 69. NEC Software Recent Development Table 70. InHealth Intelligence Company Information Table 71. InHealth Intelligence Business Overview Table 72. InHealth Intelligence Diabetic Retinopathy Screening Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. InHealth Intelligence Diabetic Retinopathy Screening Solution Product Portfolio Table 74. InHealth Intelligence Recent Development Table 75. RetinaRisk Company Information Table 76. RetinaRisk Business Overview Table 77. RetinaRisk Diabetic Retinopathy Screening Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. RetinaRisk Diabetic Retinopathy Screening Solution Product Portfolio Table 79. RetinaRisk Recent Development Table 80. Thirona Retina Company Information Table 81. Thirona Retina Business Overview Table 82. Thirona Retina Diabetic Retinopathy Screening Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Thirona Retina Diabetic Retinopathy Screening Solution Product Portfolio Table 84. Thirona Retina Recent Development Table 85. Synapxe Company Information Table 86. Synapxe Business Overview Table 87. Synapxe Diabetic Retinopathy Screening Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Synapxe Diabetic Retinopathy Screening Solution Product Portfolio Table 89. Synapxe Recent Development Table 90. Eyenuk Company Information Table 91. Eyenuk Business Overview Table 92. Eyenuk Diabetic Retinopathy Screening Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Eyenuk Diabetic Retinopathy Screening Solution Product Portfolio Table 94. Eyenuk Recent Development Table 95. EyRIS (SELENA+) Company Information Table 96. EyRIS (SELENA+) Business Overview Table 97. EyRIS (SELENA+) Diabetic Retinopathy Screening Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. EyRIS (SELENA+) Diabetic Retinopathy Screening Solution Product Portfolio Table 99. EyRIS (SELENA+) Recent Development Table 100. Vistel Company Information Table 101. Vistel Business Overview Table 102. Vistel Diabetic Retinopathy Screening Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Vistel Diabetic Retinopathy Screening Solution Product Portfolio Table 104. Vistel Recent Development Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Diabetic Retinopathy Screening Solution Product Image Figure 2. Global Diabetic Retinopathy Screening Solution Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diabetic Retinopathy Screening Solution Market Size (2021-2032) & (US$ Million) Figure 4. Global Diabetic Retinopathy Screening Solution Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Traditional Image Figure 8. Artificial Intelligence Image Figure 9. Others Image Figure 10. Global Diabetic Retinopathy Screening Solution Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Diabetic Retinopathy Screening Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Diabetic Retinopathy Screening Solution Sales Value Share by Type (2021-2032) Figure 13. Medical Industry Image Figure 14. Scientific Research Image Figure 15. Others Image Figure 16. Global Diabetic Retinopathy Screening Solution Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Diabetic Retinopathy Screening Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Diabetic Retinopathy Screening Solution Sales Value Share by Application (2021-2032) Figure 19. Global Diabetic Retinopathy Screening Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Diabetic Retinopathy Screening Solution Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Diabetic Retinopathy Screening Solution Sales Value (2021-2032) & (US$ Million) Figure 22. North America Diabetic Retinopathy Screening Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Diabetic Retinopathy Screening Solution Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Diabetic Retinopathy Screening Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Diabetic Retinopathy Screening Solution Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Diabetic Retinopathy Screening Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Diabetic Retinopathy Screening Solution Sales Value (2021-2032) & (US$ Million) Figure 28. South America Diabetic Retinopathy Screening Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Diabetic Retinopathy Screening Solution Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Diabetic Retinopathy Screening Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Traditional
  • Artificial Intelligence
  • Others
Applications
  • Medical Industry
  • Scientific Research
  • Others
Companies covered
  • RETINA-AI Health
  • IRIS
  • Retina Labs
  • CheckEye
  • RetinaLyze
  • NEC Software
  • InHealth Intelligence
  • RetinaRisk
  • Thirona Retina
  • Synapxe
  • Eyenuk
  • EyRIS (SELENA+)
  • Vistel

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Diabetic Retinopathy Screening Solution Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Diabetic Retinopathy Screening Solution Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Diabetic Retinopathy Screening Solution Market Dynamics
  1. 2.1 Diabetic Retinopathy Screening Solution Industry Trends
  2. 2.2 Diabetic Retinopathy Screening Solution Industry Drivers
  3. 2.3 Diabetic Retinopathy Screening Solution Industry Opportunities and Challenges
  4. 2.4 Diabetic Retinopathy Screening Solution Industry Restraints
3 Diabetic Retinopathy Screening Solution Market by Company
  1. 3.1 Global Diabetic Retinopathy Screening Solution Company Revenue Ranking in 2025
  2. 3.2 Global Diabetic Retinopathy Screening Solution Revenue by Company (2021-2026)
  3. 3.3 Global Diabetic Retinopathy Screening Solution Company Ranking (2024-2026)
  4. 3.4 Global Diabetic Retinopathy Screening Solution Company Manufacturing Base and Headquarters
  5. 3.5 Global Diabetic Retinopathy Screening Solution Company Product Type and Application
  6. 3.6 Global Diabetic Retinopathy Screening Solution Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Diabetic Retinopathy Screening Solution Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Diabetic Retinopathy Screening Solution Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Diabetic Retinopathy Screening Solution Market by Type
  1. 4.1 Diabetic Retinopathy Screening Solution Type Introduction
  2. 4.1.1 Traditional
  3. 4.1.2 Artificial Intelligence
  4. 4.1.3 Others
  5. 4.2 Global Diabetic Retinopathy Screening Solution Sales Value by Type
  6. 4.2.1 Global Diabetic Retinopathy Screening Solution Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Diabetic Retinopathy Screening Solution Sales Value by Type (2021-2032)
  8. 4.2.3 Global Diabetic Retinopathy Screening Solution Sales Value Share by Type (2021-2032)
5 Diabetic Retinopathy Screening Solution Market by Application
  1. 5.1 Diabetic Retinopathy Screening Solution Application Introduction
  2. 5.1.1 Medical Industry
  3. 5.1.2 Scientific Research
  4. 5.1.3 Others
  5. 5.2 Global Diabetic Retinopathy Screening Solution Sales Value by Application
  6. 5.2.1 Global Diabetic Retinopathy Screening Solution Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Diabetic Retinopathy Screening Solution Sales Value by Application (2021-2032)
  8. 5.2.3 Global Diabetic Retinopathy Screening Solution Sales Value Share by Application (2021-2032)
6 Diabetic Retinopathy Screening Solution Regional Value Analysis
  1. 6.1 Global Diabetic Retinopathy Screening Solution Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Diabetic Retinopathy Screening Solution Sales Value by Region (2021-2032)
  3. 6.2.1 Global Diabetic Retinopathy Screening Solution Sales Value by Region: 2021-2026
  4. 6.2.2 Global Diabetic Retinopathy Screening Solution Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Diabetic Retinopathy Screening Solution Sales Value (2021-2032)
  7. 6.3.2 North America Diabetic Retinopathy Screening Solution Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Diabetic Retinopathy Screening Solution Sales Value (2021-2032)
  10. 6.4.2 Europe Diabetic Retinopathy Screening Solution Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Diabetic Retinopathy Screening Solution Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Diabetic Retinopathy Screening Solution Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Diabetic Retinopathy Screening Solution Sales Value (2021-2032)
  16. 6.6.2 South America Diabetic Retinopathy Screening Solution Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Diabetic Retinopathy Screening Solution Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Diabetic Retinopathy Screening Solution Sales Value Share by Country, 2025 VS 2032
7 Diabetic Retinopathy Screening Solution Country-level Value Analysis
  1. 7.1 Global Diabetic Retinopathy Screening Solution Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Diabetic Retinopathy Screening Solution Sales Value by Country (2021-2032)
  3. 7.2.1 Global Diabetic Retinopathy Screening Solution Sales Value by Country (2021-2026)
  4. 7.2.2 Global Diabetic Retinopathy Screening Solution Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Diabetic Retinopathy Screening Solution Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Diabetic Retinopathy Screening Solution Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Diabetic Retinopathy Screening Solution Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 RETINA-AI Health
  2. 8.1.1 RETINA-AI Health Company Information
  3. 8.1.2 RETINA-AI Health Business Overview
  4. 8.1.3 RETINA-AI Health Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  5. 8.1.4 RETINA-AI Health Diabetic Retinopathy Screening Solution Product Portfolio
  6. 8.1.5 RETINA-AI Health Recent Developments
  7. 8.2 IRIS
  8. 8.2.1 IRIS Company Information
  9. 8.2.2 IRIS Business Overview
  10. 8.2.3 IRIS Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  11. 8.2.4 IRIS Diabetic Retinopathy Screening Solution Product Portfolio
  12. 8.2.5 IRIS Recent Developments
  13. 8.3 Retina Labs
  14. 8.3.1 Retina Labs Company Information
  15. 8.3.2 Retina Labs Business Overview
  16. 8.3.3 Retina Labs Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Retina Labs Diabetic Retinopathy Screening Solution Product Portfolio
  18. 8.3.5 Retina Labs Recent Developments
  19. 8.4 CheckEye
  20. 8.4.1 CheckEye Company Information
  21. 8.4.2 CheckEye Business Overview
  22. 8.4.3 CheckEye Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CheckEye Diabetic Retinopathy Screening Solution Product Portfolio
  24. 8.4.5 CheckEye Recent Developments
  25. 8.5 RetinaLyze
  26. 8.5.1 RetinaLyze Company Information
  27. 8.5.2 RetinaLyze Business Overview
  28. 8.5.3 RetinaLyze Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  29. 8.5.4 RetinaLyze Diabetic Retinopathy Screening Solution Product Portfolio
  30. 8.5.5 RetinaLyze Recent Developments
  31. 8.6 NEC Software
  32. 8.6.1 NEC Software Company Information
  33. 8.6.2 NEC Software Business Overview
  34. 8.6.3 NEC Software Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  35. 8.6.4 NEC Software Diabetic Retinopathy Screening Solution Product Portfolio
  36. 8.6.5 NEC Software Recent Developments
  37. 8.7 InHealth Intelligence
  38. 8.7.1 InHealth Intelligence Company Information
  39. 8.7.2 InHealth Intelligence Business Overview
  40. 8.7.3 InHealth Intelligence Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  41. 8.7.4 InHealth Intelligence Diabetic Retinopathy Screening Solution Product Portfolio
  42. 8.7.5 InHealth Intelligence Recent Developments
  43. 8.8 RetinaRisk
  44. 8.8.1 RetinaRisk Company Information
  45. 8.8.2 RetinaRisk Business Overview
  46. 8.8.3 RetinaRisk Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  47. 8.8.4 RetinaRisk Diabetic Retinopathy Screening Solution Product Portfolio
  48. 8.8.5 RetinaRisk Recent Developments
  49. 8.9 Thirona Retina
  50. 8.9.1 Thirona Retina Company Information
  51. 8.9.2 Thirona Retina Business Overview
  52. 8.9.3 Thirona Retina Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Thirona Retina Diabetic Retinopathy Screening Solution Product Portfolio
  54. 8.9.5 Thirona Retina Recent Developments
  55. 8.10 Synapxe
  56. 8.10.1 Synapxe Company Information
  57. 8.10.2 Synapxe Business Overview
  58. 8.10.3 Synapxe Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Synapxe Diabetic Retinopathy Screening Solution Product Portfolio
  60. 8.10.5 Synapxe Recent Developments
  61. 8.11 Eyenuk
  62. 8.11.1 Eyenuk Company Information
  63. 8.11.2 Eyenuk Business Overview
  64. 8.11.3 Eyenuk Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Eyenuk Diabetic Retinopathy Screening Solution Product Portfolio
  66. 8.11.5 Eyenuk Recent Developments
  67. 8.12 EyRIS (SELENA+)
  68. 8.12.1 EyRIS (SELENA+) Company Information
  69. 8.12.2 EyRIS (SELENA+) Business Overview
  70. 8.12.3 EyRIS (SELENA+) Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  71. 8.12.4 EyRIS (SELENA+) Diabetic Retinopathy Screening Solution Product Portfolio
  72. 8.12.5 EyRIS (SELENA+) Recent Developments
  73. 8.13 Vistel
  74. 8.13.1 Vistel Company Information
  75. 8.13.2 Vistel Business Overview
  76. 8.13.3 Vistel Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Vistel Diabetic Retinopathy Screening Solution Product Portfolio
  78. 8.13.5 Vistel Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst